Daily Derm Times: July 11, 2025

Author(s):

Emma Andrus, Editor

Key Takeaways

Recent FDA approvals and pipeline developments are shaping the dermatology landscape in 2025, with significant implications for treatment options.
GEP testing is enhancing personalized care in melanoma and SCC, moving beyond traditional staging methods.
Diagnostic challenges in treating scalp disorders in patients with skin of color highlight the need for improved training and protocols.
Dual therapy with upadacitinib and excimer laser demonstrates efficacy in treating refractory vitiligo, achieving a 55% remission rate.
Ethanol-based hand sanitizers show no visible dermal toxicity, but concerns about subclinical dermatitis suggest further testing is needed.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

FDA News and Decisions: Midyear Updates

Exclusive Report: A comprehensive look at the latest FDA approvals and pipeline developments in dermatology from the first half of 2025.

How GEP Testing is Personalizing Skin Cancer Care Beyond Staging

At a recent Dermatology Times Case-Based Roundtable event, Gaurav Singh, MD, MPH, FAAD, FACMS, utilized 3 patient cases to explore the role of GEP testing in melanoma and SCC.

Scalp Disorders in SoC: A Diagnostic Blind Spot

A systematic review reveals critical diagnostic gaps in hair loss treatment for patients with skin of color, urging improved training and protocols in dermatology.

Upadacitinib Plus Excimer Laser Efficacious in Treating Refractory Vitiligo With Moderate to Severe Atopic Dermatitis

After 4 months of treatment with the dual therapy, patients with refractory vitiligo exhibited an overall 55% remission rate.

Ethanol-Based Hand Sanitizer Shows No Visible Dermal Toxicity; Further Testing Warranted

Ethanol-based hand sanitizer showed no visible skin toxicity in rats, but subclinical dermatitis raised concerns about dermal test guideline adequacy.

Think Like a CEO: Financial Tips for Physicians

OJM Group’s David Mandell, JD, MBA, shares financial planning strategies for physicians facing new tax laws and market volatility.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!